Form 4: Sutro Biopharma Executive Linda Fitzpatrick Reports Stock Transactions
SEC Form 4 Filing
Linda Fitzpatrick, Chief People & Communications Officer at Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Summary
- Linda Fitzpatrick, Chief People & Communications Officer of Sutro Biopharma, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- On March 1, 2024, 6,875 restricted stock units (RSUs) vested, converting into common stock.
- Simultaneously, 2,511 shares were withheld by Sutro Biopharma to cover income tax obligations at a price of $4.95 per share.
- Fitzpatrick directly owns 61,924 shares of common stock after these transactions.
- She also indirectly owns 10,383 shares through the Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company.
Key Dates
| Date | Description |
|---|---|
| 10/13/1997 | Date of the Michael A. & Linda A. Fitzpatrick Family Trust |
| 03/01/2024 | Date of RSU vesting and tax withholding |
| 03/01/2027 | Expiration date of the Restricted Stock Units |
| 03/05/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.